₹945.46
Below FV▲ +67.5% against the close used
Model range ₹365.81 – ₹1,550.83
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Bear₹365.81Fair value₹945.46Bull₹1,550.83
FairClose
52-week traded range
52W low ₹520.3052W high ₹866.20
The 52-week range is measured from the stored price history, not estimated.
Trading below the consensus fair value
Krsnaa Diagnostics Ltd closed at ₹564.40, 40.3% below the consensus fair value of ₹945.46 drawn from 9 valuation models.
Financial DNA score 55/100 — Good. P/E of 18.3x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
DCF Valuation
₹620.68
+10.0%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
₹458.37
-18.8%
√(22.5 × EPS × BVPS)
EPS=31.27, BVPS=298.62 · outside Graham range (P/E 18.3, P/B 1.9) — asset-light, treat as a rough floor
Graham Formula
₹1,205.01
+113.5%
EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate
g=16.5%, FD=7%
P/E Fair Value
₹1,314.90
+133.0%
EPS × 42.05x (sector P/E)
EPS=31.27, Sector P/E=42.05x
Peter Lynch (PEG)
₹515.96
-8.6%
EPS × Growth% (PEG = 1 is fair)
EPS=31.27, g=16.5%
EV/EBITDA
₹1,550.83
+174.8%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=3.02B
Book Value (P/B)
₹365.81
-35.2%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=298.62, ROE=10.9%, g=6%, r=10%
Reverse DCF
₹564.40
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 5.8% | Historical: 16.5%
Margin of Safety
₹674.81
+19.6%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=899.74, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.